Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, United Kingdom.
Trends Immunol. 2010 Apr;31(4):164-9. doi: 10.1016/j.it.2010.01.006. Epub 2010 Feb 22.
Protein arginine methylation has emerged as a key regulator of signal transduction with an important role in T lymphocyte activation. The predominant methyl transferase PRMT-1 is highly expressed in T helper cells, and ligation of the T cell antigen and costimulatory receptors, induces arginine methylation on several cytoplasmic proteins. Global inhibition of methyl transferases can result in signaling defects in CD4 T cells and profound immunosuppression. Here we suggest that manipulating protein arginine methylation could be a feasible strategy to modulate T lymphocyte function, presenting a novel approach towards immunotherapy and the treatment of T cell-mediated disorders such as autoimmune disease and transplant rejection.
蛋白质精氨酸甲基化已成为信号转导的关键调节剂,在 T 淋巴细胞激活中发挥重要作用。主要的甲基转移酶 PRMT-1 在辅助性 T 细胞中高度表达,T 细胞抗原和共刺激受体的连接诱导几种细胞质蛋白的精氨酸甲基化。甲基转移酶的全局抑制可导致 CD4 T 细胞的信号缺陷和严重的免疫抑制。在这里,我们提出操纵蛋白质精氨酸甲基化可能是调节 T 淋巴细胞功能的一种可行策略,为免疫治疗和 T 细胞介导的疾病(如自身免疫性疾病和移植排斥)的治疗提供了一种新方法。